XML 75 R110.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Selected Quarterly Financial Information (unaudited) Selected Quarterly Financial Information Narrative Details (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Selected Quarterly Financial Information [Line Items]                      
Up-front collaboration and licensing expenses related to Galapagos                 $ 9,106 $ 5,018 $ 3,734
Income Tax Expense (Benefit)                 (204) 2,339 8,885
Net gains from equity securities                 (1,200) (115)  
Impairment charge related to IPR&D intangible asset $ 800       $ 820       800 820 $ 0
Inventory write-downs                 $ 649 $ 572  
Net income per share attributable to Gilead common stockholders - basic $ 2.13 $ (0.92) $ 1.48 $ 1.55 $ 0 $ 1.62 $ 1.40 $ 1.18 $ 4.24 $ 4.20 $ 3.54
Net income per share attributable to Gilead common stockholders - diluted $ 2.12 $ (0.92) $ 1.47 $ 1.54 $ 0 $ 1.60 $ 1.39 $ 1.17 $ 4.22 $ 4.17 $ 3.51
Upfront collaboration and licensing expense [Member]                      
Selected Quarterly Financial Information [Line Items]                      
Up-front collaboration and licensing expenses related to Galapagos   $ 3,920                  
Intangible Asset Transfer [Member]                      
Selected Quarterly Financial Information [Line Items]                      
Income Tax Expense (Benefit) $ (1,200)       $ 588            
Inventory write-downs for excess raw materials                      
Selected Quarterly Financial Information [Line Items]                      
Inventory write-downs $ 500       $ 410       $ 547 $ 440  
Upfront collaboration and licensing expense [Member]                      
Selected Quarterly Financial Information [Line Items]                      
Net income per share attributable to Gilead common stockholders - basic   $ 2.40                  
Net income per share attributable to Gilead common stockholders - diluted   $ 2.40                  
Unfavorable EPS Impact [Member]                      
Selected Quarterly Financial Information [Line Items]                      
Net income per share attributable to Gilead common stockholders - basic         $ (1.31)            
Net income per share attributable to Gilead common stockholders - diluted         $ (1.30)            
Favorable EPS Impact [Member]                      
Selected Quarterly Financial Information [Line Items]                      
Net income per share attributable to Gilead common stockholders - basic $ 0.83                    
Net income per share attributable to Gilead common stockholders - diluted $ 0.81                    
Intangible Asset Transfer [Member]                      
Selected Quarterly Financial Information [Line Items]                      
Net gains from equity securities $ (929)